Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis.
Emerging role of interleukin-22 in autoimmune diseases.
Specialized housing and transportation needs of adults with multiple sclerosis.
Vitamin D immunomodulatory potential in multiple sclerosis.
Multiple sclerosis in New Zealand.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Seizure characteristics in multiple sclerosis patients.
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
Structural brain lesions in inflammatory bowel disease.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Voice-related quality of life in patients with multiple sclerosis.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.

Pages